ALIDYA Anti LipoDystrophic Agents
zoom_out_map
chevron_left chevron_right

ALIDYA Anti LipoDystrophic Agents

THE FIRST INJECTABLE DEVICE. REMOVES CELLULITE AND BRINGS MAINTAINING RESULTS. PRODUCT FOR MEDICAL USE ONLY. Particularly indicated for prevention and the treatment of gynoid lipodystrophy (cellulitis). First registered medicinal product for cellulite treatment. (5X340mg vials with powder + 5X10ml vials with solvent).

€87.50 (tax incl.) €87.50 (tax excl.)
Tax excluded

Description

ALIDYA Anti LipoDystrophic Agents

ALIDYA Anti LipoDystrophic Agents MARLLOR BIOMEDICAL. MEDICAL USE ONLY. Marllor Biomedical Srl Via Torconca, 1 47842 S. Giovanni in Marignano (RN).

DESCRIPTION

ALIDYA is supplied in a package containing 5 vials each containing 340mg of powder and 5 vials of 10ml of solvent. (5X340mg powder vials+5X10ml solvent bottles). ALIDYA is the first injectable device specifically indicated for the prevention and treatment of gynoid lipodystrophy (cellulitis). ALIDYA, developed for the reduction not procedure for localized fat under the skin, is an injectable aqueous solution, gel-based, which dissolves fat and is biocompatible and biodegradable. The action of ALIDYA is achieved by solubilization and therefore elimination of these extracellular toxic elements, as well as the restoration of normal cellular homeostasis, which clinically translates into an improvement of affected areas or a predisposition to the development of cellulite. THE FIRST INJECTABLE DEVICE particularly suitable for the prevention and treatment of gynoid lipodystrophy (cellulitis). Resulting from studies carried out by Professor Pasquale Motolese, who identified as a contributing factor to the genesis of cellulite, the presence of extracellular toxic ions, deposited following alterations in the vascular microcirculation.

CONDITIONING ALIDYA

The product is supplied in a pack of 5 vials each containing 340 mg of powder and 5 vials of 10 ml of solvent.

ACTION ALIDYA

The action of ALIDYA is expressed by solubilization, and as a consequence of the elimination of these extracellular toxic elements, as well as the restoration of normal cellular omeostasis, clinically translates into the improvement of the area affected or predisposed to the development of cellulite.

COMPOSITION ALIDYA

  • Polyamino Acid Gel
  • D-(+) Glucopyranose Α
  • 1-4 Glucoside
  • Ethylenediaminetetraacetic Sodium
  • Amino Acid Buffer System With Sodium Bicarbonate Corrector
  • Osmolarity Regulator.

INSTRUCTIONS

Recommended for:

  • Remove stubborn fat when exercise and diet can't eliminate cellulite and fatty deposits.
  • Treating pseudo-gynecomastia in men.
  • Thighs, knees, buttocks, hips, stomach, chin and double chin, lower cheeks.
  • Can be administered in many areas all over the body, e.g. double chin, prejowl sulcus, arms, arms, waist, hips, saddlebags, knees, hobbles, increased fat deposits located on the buttocks, chest and thighs.

CONTRAINDICATION

Pregnant or breastfeeding women should not use Aqualyx for the safety of their growing baby. Additionally, persons with liposdystrophy, pathological conditions, or under the age of 18 and over 60, should not use this product.

TIPS

Do not apply cosmetics to the treated area within 12 hours and avoid direct sources of heat and radiation (sunlight, UV rays, sauna, etc.).

USE

CE marked injectable device formulated by Prof. P.Motolese. Alidya™ must be injected using the mesotherapy technique in the area affected by gnnoid lipodystrophy “cellulite” in weekly sessions. The ALIDYA treatment requires an average minimum of 7 applications in the specific area to be treated, up to a maximum of 12 treatments. They are to be applied on a weekly basis, at the rate of 1 to 2 vials per session, depending on the extent of the area to be treated.

ITS FORMULA IS DESIGNED FOR

  • solubilize and eliminate toxic extracellular elements secondary to vascular damage in the microcirculation
  • alkalinize the extracellular matrix
  • improve tissue oxygenation
  • provide the biological components for the restructuring of the extracellular matrix
  • normalize the physiological function of adipose tissue
  • ALIDYA is the result of the most recent research on the pathophysiology called gynoid lipodystrophy.

Data sheet

0.08 kg
30049000

You might also like